|
|||
|
Multiple Sclerosis Info
|
Monday, February 18
by
multiplesclerosis
on Mon 18 Feb 2008 05:02 PM CST
Treosulfan (L-threitol-1,4-bis(methanesulfonate)) is a bifunctional alkylating agent with a favourable profile of side effects, approved for the treatment of ovarian cancer. Treosulfan has previously been shown to reduce the severity more »
by
multiplesclerosis
on Mon 18 Feb 2008 02:56 PM CST
Type 1 diabetes mellitus (T1D) and multiple sclerosis (MS) contribute considerably to the burden of autoimmune diseases in young adults. Although HLA patterns of T1D and MS are considered mutually exclusive, individual and familial co-occurrence more »
by
multiplesclerosis
on Mon 18 Feb 2008 01:46 PM CST
![]() Conduction in a Demyelinated Nerve Fiber-KHThis slide shows abnormal conduction in a nerve fiber in demyelinating diseases.
by
multiplesclerosis
on Mon 18 Feb 2008 09:14 AM CST
Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body’s central nervous system.
Recognizing that pattern, researchers from the more »
by
multiplesclerosis
on Mon 18 Feb 2008 03:00 AM CST
Objective:
To examine the relation between low-contrast letter acuity, an emerging visual outcome for multiple sclerosis (MS) clinical trials, and more »
by
multiplesclerosis
on Mon 18 Feb 2008 01:00 AM CST
For many people with MS, one of the early symptoms is a problem with vision. This may be in the form of temporary loss or blurring of vision, or double vision.
Most people with MS who experience visual symptoms more »
by
multiplesclerosis
on Mon 18 Feb 2008 12:00 AM CST
Although most hypersensitive reactions to natalizumab (Tysabri) occur within hours of the first dose, such responses may be delayed, according to more »
|
||
